{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T21:16:13Z","timestamp":1776978973284,"version":"3.51.4"},"reference-count":19,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2016,9,30]],"date-time":"2016-09-30T00:00:00Z","timestamp":1475193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematology Reports"],"abstract":"<jats:p>Paroxysmal nocturnal hemoglobinuria (PNH) is associated with severe end-organ damage and a high risk of thrombosis. Budd- Chiari syndrome, which develops after thrombotic occlusion of major hepatic blood vessels, is relatively common in PNH and has been associated with increased mortality. We report the case of a 46-year-old male with PNH who presented with Budd-Chiari syndrome associated with portal cavernoma, portal hypertension and hypersplenism. In September 2010, the patient suffered gastrointestinal bleeding, hematuria, and elevated plasma lactate dehydrogenase; he started eculizumab therapy with a good response. In October 2012, he developed upper gastrointestinal variceal bleeding and a splenorenal shunt was placed. At the time of writing, the patient remains stable and eculizumab continues to be effective. There is limited data on the use of eculizumab for prevention of hemolysis and its consequences in PNH patients undergoing surgery. Our findings provide evidence for the efficacy and safety of eculizumab in this setting.<\/jats:p>","DOI":"10.4081\/hr.2016.6562","type":"journal-article","created":{"date-parts":[[2016,9,30]],"date-time":"2016-09-30T13:24:00Z","timestamp":1475241840000},"page":"34-36","source":"Crossref","is-referenced-by-count":7,"title":["Positive Impact of Eculizumab Therapy on Surgery for Budd- Chiari Syndrome in a Patient with Paroxysmal Nocturnal Hemoglobinuria and a Longterm History of Thrombosis"],"prefix":"10.3390","volume":"8","author":[{"given":"Silvia","family":"De-la-Iglesia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo","family":"Luzardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelina","family":"Lemes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"G\u00f3mez-Casares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naylen","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Molero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2016,9,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1182\/blood.V86.9.3277.bloodjournal8693277","article-title":"The molecular basis of paroxysmal nocturnal hemoglobinuria","volume":"86","author":"Rosse","year":"1995","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0140-6736(95)12360-1","article-title":"Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology","volume":"348","author":"Soci\u00e9","year":"1996","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3324\/haematol.2009.017848","article-title":"Paroxysmal nocturnal hemoglobinuria and eculizumab","volume":"95","author":"Luzzatto","year":"2010","journal-title":"Haematologica"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1182\/blood-2007-06-095646","article-title":"Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria","volume":"110","author":"Hillmen","year":"2007","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jhep.2009.06.019","article-title":"Paroxysmal nocturnal hemoglobinuria in Budd-Chiari syndrome: findings from a cohort study","volume":"51","author":"Hoekstra","year":"2009","journal-title":"J Hepatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1182\/blood-2012-09-311381","article-title":"Thrombosis in paroxysmal nocturnal hemoglobinuria","volume":"121","author":"Hill","year":"2013","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.2165\/11208300-000000000-00000","article-title":"Eculizumab: a review of its use in paroxysmal nocturnal haemoglobinuria","volume":"71","author":"McKeage","year":"2011","journal-title":"Drugs"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1182\/blood-2008-01-133918","article-title":"Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories","volume":"112","author":"de Latour","year":"2008","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/lt.21714","article-title":"Successful liver transplantation for Budd-Chiari syndrome in a patient with paroxysmal nocturnal hemoglobinuria treated with the anti-complement antibody eculizumab","volume":"15","author":"Singer","year":"2009","journal-title":"Liver Transpl"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s12185-013-1346-4","article-title":"Clinical signs and symptoms associated with increased risk for thrombosis in patients with paroxysmal nocturnal hemoglobinuria from a Korean Registry","volume":"97","author":"Lee","year":"2013","journal-title":"Int J Hematol"},{"key":"ref11","first-page":"428","article-title":"Thrombotic complications in paroxysmal nocturnal haemoglobinuria: a literature review","volume":"10","author":"Malato","year":"2012","journal-title":"Blood Transfus"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00000539-200010000-00050","article-title":"The anesthetic management of a patient with paroxysmal nocturnal hemoglobinuria","volume":"91","author":"Kathirvel","year":"2000","journal-title":"Anesth Analg"},{"key":"ref13","first-page":"172","article-title":"Acute renal failure in a patient with paroxysmal nocturnal hemoglobinuria","volume":"56","author":"Jose","year":"2001","journal-title":"Clin Nephrol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s00277-012-1514-2","article-title":"Successful cholecystectomy in a patient with aplastic anemia-paroxysmal nocturnal hemoglobinuria during eculizumab treatment","volume":"91","author":"Ando","year":"2012","journal-title":"Ann Hematol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.2169\/internalmedicine.51.8202","article-title":"Successful management of obstructive jaundice due to gallstones with eculizumab in a patient with paroxysmal nocturnal hemoglobinuria","volume":"51","author":"Kawano","year":"2012","journal-title":"Intern Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40792-015-0059-8","article-title":"A patient with paroxysmal nocturnal hemoglobinuria being treated with eculizumab who underwent laparoscopic cholecystectomy: report of a case","volume":"1","author":"Moriyama","year":"2015","journal-title":"Surg Case Rep"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1600-0609.2011.01656.x","article-title":"Cardiopulmonary bypass in a patient with classic paroxysmal nocturnal hemoglobinuria during treatment with eculizumab","volume":"87","author":"van Bijnen","year":"2011","journal-title":"Eur J Haematol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood-2008-04-151613","article-title":"Hemoglobin normalization after splenectomy in a paroxysmal nocturnal hemoglobinuria patient treated by eculizumab","volume":"112","author":"Risitano","year":"2008","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF02983209","article-title":"Clinical manifestations of paroxysmal nocturnal hemoglobinuria: present state and future problems","volume":"77","author":"Rosse","year":"2003","journal-title":"Int J Hematol"}],"container-title":["Hematology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.pagepress.org\/journals\/index.php\/hr\/article\/viewFile\/6562\/6474","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.mdpi.com\/2038-8330\/8\/3\/6562\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T07:09:28Z","timestamp":1645600168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2038-8330\/8\/3\/6562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,30]]},"references-count":19,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,9]]}},"alternative-id":["hr.2016.6562"],"URL":"https:\/\/doi.org\/10.4081\/hr.2016.6562","relation":{},"ISSN":["2038-8330"],"issn-type":[{"value":"2038-8330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,30]]}}}